TLT.V - Theralase Technologies Inc.

TSXV - TSXV Delayed Price. Currency in CAD
+0.01 (+2.13%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.47
Bid0.47 x 0
Ask0.48 x 0
Day's Range0.47 - 0.48
52 Week Range0.18 - 0.55
Avg. Volume327,485
Market Cap60.71M
PE Ratio (TTM)-10.21
EPS (TTM)-0.05
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Baystreetlast month

    Stocks in play: Theralase Technologies Inc.

    Has demonstrated increased efficacy with its latest, patented, licensed, anti-cancer drug, TLD-1633, ...

  • We're sorry this is all we were able to find about this topic.